Matinas Biopharma Holdings Inc [MTNB] stock prices are down -0.85% to $0.15 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The MTNB shares have lost -3.30% over the last week, with a monthly amount drifted -9.83%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Matinas Biopharma Holdings Inc [AMEX: MTNB] stock has seen the most recent analyst activity on May 11, 2021, when Piper Sandler downgraded its rating to a Neutral. On January 27, 2020, Piper Sandler initiated with a Overweight rating and assigned a price target of $3 on the stock. SunTrust started tracking the stock assigning a Buy rating. SunTrust initiated its recommendation with a Buy. Aegis Capital started tracking with a Buy rating for this stock on January 09, 2020, and assigned it a price target of $3.50. In a note dated June 26, 2019, H.C. Wainwright initiated an Buy rating and provided a target price of $4 on this stock.
The stock price of Matinas Biopharma Holdings Inc [MTNB] has been fluctuating between $0.11 and $0.89 over the past year. Matinas Biopharma Holdings Inc [AMEX: MTNB] shares were valued at $0.15 at the most recent close of the market.
Analyzing the MTNB fundamentals
The Matinas Biopharma Holdings Inc [AMEX:MTNB] reported sales of 0.00M for trailing twelve months, representing a drop of -100.00%. Gross Profit Margin for this corporation currently stands at 1.87% with Operating Profit Margin at 21.97%, Pretax Profit Margin comes in at 21.22%, and Net Profit Margin reading is 21.22%. To continue investigating profitability, this company’s Return on Assets is posted at -1.19, Equity is -1.1 and Total Capital is -1.37. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.23.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.1470 points at the first support level, and at 0.1416 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.1563, and for the 2nd resistance point, it is at 0.1602.
Ratios To Look Out For
It’s worth pointing out that Matinas Biopharma Holdings Inc [AMEX:MTNB]’s Current Ratio is 5.15. In addition, the Quick Ratio stands at 5.15 and the Cash Ratio stands at 0.56.
